Unlocking the Potential of Technology for the Benefit of Health in China
-
Press releases2019-11-04MMMM DD YYYYSanofi : FDA approves Fluzone® High-Dose Quadrivalent (Influenza Vaccine) for adults 65 years of age and older
This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies.